HOME >> BIOLOGY >> NEWS
Third Wave scientists publish advance in gene expression monitoring with revolutionary RNA Invader Assay

MADISON, Wis. July 2, 2001 Scientists at Third Wave Technologies Inc. (Nasdaq: TWTI) have validated a technological breakthrough with the potential to revolutionize the analysis of gene expression for research and clinical applications including genome research, drug development and disease monitoring.

Third Waves Invader technology is capable of identifying and quantitating low levels of unique RNAs directly from total RNA or crude cell samples called cell lysates, according to findings published in the July issue of Nature Biotechnology. Direct detection of gene expression levels with Invader technology eliminates several costly, time-consuming steps required by other technologies and minimizes the risk of sample contamination.

"The ability to analyze for RNA easily and directly, without complicated procedures that can contaminate the sample, is a significant advance in RNA detection technology and the efforts to understand diseases and develop drugs to treat them," said Lance Fors, Ph.D., president and chief executive officer of Third Wave Technologies.

Key Findings Reported in Nature Biotechnology: RNA Invader Assay

  • Direct Detection. The RNA Invader assay enables identification and quantitation directly from total RNA or crude cell lysate samples prepared using a simple and inexpensive process. Many RNA tests require high-purity RNA purification, often in combination with time-consuming and expensive multi-step preparation of the RNA samples before they can be tested. A method known as RT-PCR is among the most commonly used. It includes RNA purification, transcription of the RNA to its DNA complement and creation of additional copies of the DNA again and again prior to detection. RT-PCR methods are inherently less accurate than direct RNA detection and test results can be skewed by sample contamination.
  • Accuracy and Precision. The RNA Invader assay is capable of detecting changes in gene expression levels as
    '"/>


Contact: Beth Preston
epreston@fkhealth.com
617-761-6739
Feinstein Kean Healthcare
2-Jul-2001


Page: 1 2 3

Related biology news :

1. Popular Science announces Third Annual Brilliant 10
2. Third set of awards are announced under interagency biodiversity program
3. Large brains not required? Third and smallest skull of first Eurasians reported in Science
4. Rutgers scientists create high-protein corn with Third World potential
5. Third piece completes deadly puzzle: Structure of anthrax toxin offers clues to treatment
6. University Of Kentucky Researcher Awarded MERIT Extension For Study Of Third World Killer
7. Third Annual Awards For Presidential Green Chemistry Challenge Recognize Innovations
8. Fortified Drink Improves Third World Nutrition
9. DNA lends scientists a hand, revealing new chemical reactions
10. Conference at UH opens doors for new scientists, engineers
11. Wisconsin scientists develop quick botox test

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/29/2019)... ... 2019 , ... In the wake of the success of ... Chinese biobanks was launched in July 2018, in an agreement between IBBL, the ... Medicinal Biotech Association (BBCMBA). The one-year pilot programme offered two testing schemes: ‘DNA ...
(Date:3/27/2019)... , ... March 27, 2019 , ... ... company has been awarded the 2019 Global Health & Pharma Biotechnology Award as ... Global Health & Pharma’s Biotechnology Awards honor individuals and companies whose accomplishments have ...
(Date:3/25/2019)... WHITEHOUSE, N.J. (PRWEB) , ... March 25, 2019 ... ... and tools, and Visikol, a contract research organisation focused on advancing drug discovery, ... clearing and 3D imaging. , Tissue clearing methods, which are essential to get ...
Breaking Biology News(10 mins):
(Date:4/15/2019)... (PRWEB) , ... April 15, 2019 , ... ... has completed construction of a $2 million bench plant expansion to increase production ... important step in the design and construction of Sirrus’ full-scale production facility, which ...
(Date:4/9/2019)... ... April 09, 2019 , ... ... increasing the capacity of life sciences organizations to accelerate innovation and maximize productivity, ... in the past 12 months. , USDM’s Cloud Assurance is ...
(Date:4/8/2019)... , ... April 08, 2019 , ... US Capital ... a $15 million preferred equity investment in the privately held pharmaceutical company, S1 Biopharma ... drug, Lorexys, is targeted at female hypoactive sexual dysfunction disorder and is ready to ...
(Date:3/29/2019)... ... March 28, 2019 , ... Specific Diagnostics announced today ... with a second stage of funding for Specific’s Reveal™ rapid antibiotic susceptibility test ... of the $1.7 million already awarded by CARB-X. The additional $1.7M will enable ...
Breaking Biology Technology:
Cached News: